XEL
67
2
IVZ
46
3
OXY
40
3
PPL
54
2
NAVI
41
-3
JPM
63
-4
AES
39
-4
MPC
47
3
MAS
51
4
ROK
55
8
STI
47
-12
KMX
58
3
TRV
53
-3
EXR
57
-2
EQIX
60
-2
ILMN
32
-3
ICE
59
-3
AIV
68
-4
AMAT
36
5
IBM
54
4
XEL
67
2
IVZ
46
3
OXY
40
3
PPL
54
2
NAVI
41
-3
JPM
63
-4
AES
39
-4
MPC
47
3
MAS
51
4
ROK
55
8
STI
47
-12
KMX
58
3
TRV
53
-3
EXR
57
-2
EQIX
60
-2
ILMN
32
-3
ICE
59
-3
AIV
68
-4
AMAT
36
5
IBM
54
4
Financhill
Back

OptimizeRx Stock Price Chart

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46

OPRX
OptimizeRx

Last Price:
4.49
Seasonality Move:
4.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

OptimizeRx Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.83 Sell
20-day SMA: 5.28 Sell
50-day SMA: 6.43 Sell
200-day SMA: 10.05 Sell
8-day EMA: 4.67 Sell
20-day EMA: 5.27 Sell
50-day EMA: 6.28 Sell
200-day EMA: 9.13 Sell

OptimizeRx Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 37.29 Sell
Chaikin Money Flow: 294877 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

OptimizeRx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for OptimizeRx Stock

Is OptimizeRx Stock a Buy?

  • OptimizeRx share price is 4.42 while OPRX 8-day simple moving average is 4.83, which is a Sell signal.
  • The stock price of OPRX is 4.42 while OptimizeRx 20-day SMA is 5.28, which makes it a Sell.
  • OptimizeRx 50-day simple moving average is 6.43 while OPRX share price is 4.42, making it a Sell technically.
  • OPRX stock price is 4.42 and OptimizeRx 200-day simple moving average is 10.05, creating a Sell signal.

OPRX Technical Analysis vs Fundamental Analysis

Sell
46
OptimizeRx (OPRX) is a Sell

Is OptimizeRx a Buy or a Sell?

  • OptimizeRx stock is rated a Sell
    The current OptimizeRx [OPRX] share price is $4.42. The Score for OPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.

OptimizeRx Stock Info

Market Cap:
81.42M
Price in USD:
4.42
Share Volume:
544.39K

OptimizeRx 52-Week Range

52-Week High:
16.65
52-Week Low:
3.78
Sell
46
OptimizeRx (OPRX) is a Sell

OptimizeRx Share Price Forecast

  • What is the OptimizeRx stock price today?
    The OptimizeRx stock price is 4.42 USD today.
  • Will OPRX stock go up or go down?
    OptimizeRx> share price is forecast to RISE/FALL based on technical indicators
  • Is OptimizeRx overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, OptimizeRx is overvalued.

Is OptimizeRx Stock a Buy?

  • OptimizeRx share price is 4.42 while OPRX 8-day exponential moving average is 4.67, which is a Sell signal.
  • The stock price of OPRX is 4.42 while OptimizeRx 20-day EMA is 5.27, which makes it a Sell.
  • OptimizeRx 50-day exponential moving average is 6.28 while OPRX share price is 4.42, making it a Sell technically.
  • OPRX stock price is 4.42 and OptimizeRx 200-day simple moving average is 9.13, creating a Sell signal.

Fundamental Analysis of OptimizeRx

Is OptimizeRx a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.07 per share.

Technical Analysis of OptimizeRx

Should I short OptimizeRx stock?

* OptimizeRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.